The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Multi-organ disorder 2
SANDOSTATIN LAR DEPOT Multiple endocrine neoplasia 2
SANDOSTATIN LAR DEPOT Musculoskeletal disorder 2
SANDOSTATIN LAR DEPOT Nail bed disorder 2
SANDOSTATIN LAR DEPOT Nasal discharge discolouration 2
SANDOSTATIN LAR DEPOT Nasal dryness 2
SANDOSTATIN LAR DEPOT Nephrosclerosis 2
SANDOSTATIN LAR DEPOT Oesophageal pain 2
SANDOSTATIN LAR DEPOT Oesophageal spasm 2
SANDOSTATIN LAR DEPOT Onychoclasis 2
SANDOSTATIN LAR DEPOT Optic nerve disorder 2
SANDOSTATIN LAR DEPOT Oral infection 2
SANDOSTATIN LAR DEPOT Osteosclerosis 2
SANDOSTATIN LAR DEPOT Overdose 2
SANDOSTATIN LAR DEPOT Papillary thyroid cancer 2
SANDOSTATIN LAR DEPOT Papule 2
SANDOSTATIN LAR DEPOT Pelvic pain 2
SANDOSTATIN LAR DEPOT Pericardial disease 2
SANDOSTATIN LAR DEPOT Peritoneal disorder 2
SANDOSTATIN LAR DEPOT Phlebitis 2

Total Records: 2,045     Number of Pages: 103